Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AKST4290 adjunctive treatment for mild to moderate bullous pemphigoid
2019-001059-37Phase 2Completed
- Sponsor
- Alkahest, Inc.
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BI 144807 in Bullous Pemphigoid (BP), sponsored by Alkahest, Inc.. Started Jun 2019; status: completed.
02
Drugs
BI 144807
03
Conditions
Bullous Pemphigoid (BP)
Beyond the preview
Go deeper on 2019-001059-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001059-37.